Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Medecine Sciences : M/S|March 23, 2024
[Therapeutics in cystic fibrosis: Clinical revolution and new challenges]Emmanuelle Bardin, Iwona Pranke, Alexandre Hinzpeter, et al.Journal of Breath Research|November 2, 2023
A benchmark study of data normalisation methods for PTR-TOF-MS exhaled breath metabolomicsCamille Roquencourt, Elodie Lamy, Emmanuelle Bardin, et al.La Revue Du Praticien|January 23, 2026
[Treatment perspectives for patients not eligible for therapies for cystic fibrosis]Emmanuelle Bardin, Iwona Pranke, Marie Giorgi, et al.Frontiers in Pharmacology|January 25, 2024
Therapeutic drug monitoring of corticosteroids/β2-agonists in the hair of patients with asthma: an open-label feasibility studyHélène Salvator, Elodie Lamy, Camille Roquencourt, et al.Analytical and Bioanalytical Chemistry|March 15, 2026
Soft ionization by chemical reaction in transfer-high-resolution mass spectrometry for clinical exhaled breath profilingCamille Roquencourt, Elodie Lamy, Nicolas Hunzinger, et al.The Analyst|January 4, 2023
Volatile metabolites differentiate air-liquid interface cultures after infection with Staphylococcus aureusWaqar Ahmed, Emmanuelle Bardin, Michael D Davis, et al.ERJ Open Research|September 20, 2023
Enhanced real-time mass spectrometry breath analysis for the diagnosis of COVID-19Camille Roquencourt, Hélène Salvator, Emmanuelle Bardin, et al.Analytical and Bioanalytical Chemistry|July 9, 2024
Combination of real-time and hyphenated mass spectrometry for improved characterisation of exhaled breath biomarkers in clinical researchElodie Lamy, Camille Roquencourt, Bingqing Zhou, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 1, 2026
Real-time breath metabolomics to assess early response to CFTR modulators in adults with cystic fibrosis: An open-label proof-of-concept studyEmmanuelle Bardin, Hélène Salvator, Camille Roquencourt, et al.European Journal of Medicinal Chemistry|February 1, 2021
Modulators of CFTR. Updates on clinical development and future directionsEmmanuelle Bardin, Alexandra Pastor, Michaela Semeraro, et al.Pageof 2